Anzalone Christopher Richard - Insider Non-Derivative Transactions at ARROWHEAD PHARMACEUTICALS, INC. (ARWR) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jan 31, 2024, Anzalone Christopher Richard's relationship to ARROWHEAD PHARMACEUTICALS, INC. (ARWR) is Director,Officer (Chief Executive Officer), and currently has 3,772,547 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ARWR insiders.

Data Source: SEC.
Anzalone Christopher Richard - Insider Non-Derivative Transactions of ARWR Common Stock
Anzalone Christopher Richard - Insider Non-Derivative Transactions at ARWR
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Feb 1, 2024 Sell -- (Common Stock) 19730 32.71 3715048
Feb 1, 2024 Sell -- (Common Stock) 37769 32.16 3734778
Feb 1, 2024 M -- (Common Stock) 57499 14.54 3772547
Jan 3, 2024 Sell -- (Common Stock) 5318 31.25 3715048
Jan 3, 2024 Sell -- (Common Stock) 4634 30.74 3720366
Dec 21, 2023 Sell -- (Common Stock) 12000 28.54 3725000
Oct 26, 2023 Sell -- (Common Stock) 24338 24.21 3737000
Sep 19, 2023 Sell -- (Common Stock) 26232 28.27 3761338
Sep 19, 2023 Sell -- (Common Stock) 31523 28 3787570
Sep 19, 2023 M -- (Common Stock) 57755 4.75 3819093
May 5, 2023 Sell -- (Common Stock) 25992 40.02 3761338
May 5, 2023 Sell -- (Common Stock) 24008 38.97 3787330
May 5, 2023 M -- (Common Stock) 50000 2.01 3811338
May 4, 2023 Sell -- (Common Stock) 54928 39.14 3761338
May 4, 2023 M -- (Common Stock) 54928 2.01 3816266